Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans.

Post-treatment reactions to single-dose ivermectin (200 microg/kg) and albendazole (400 mg) were studied in a filarial endemic region of Mali. The prevalence of Wuchereria bancrofti in this region was 48.3% (69 of 143), and coinfection with Mansonella perstans was common (30 of 40, 75%). Microfilarial levels of M. perstans correlated positively with age (P = 0.006) and with W. bancrofti microfilarial levels (P = 0.006). Forty individuals (28 infected and 12 uninfected) were treated, with mild post-treatment reactions occurring in 35.7% (7 of 28) of the W. bancrofti-infected subjects. Reaction severity correlated with pretreatment W. bancrofti microfilarial levels (P = 0.001). There were no significant differences in the prevalence or severity of post-treatment reactions in those who were co-infected with M. perstans. It is concluded that co-infection with M. perstans does not significantly alter the post-treatment reaction profile to single-dose ivermectin/albendazole in W. bancrofti infection in this community, and that acute post-treatment reactions should not limit patient compliance in community-based programs to eliminate lymphatic filariasis.

[1]  N. Gogtay,et al.  Reading ICT filariasis rapid diagnostic card tests under field conditions and issues of good clinical practice in clinical trials. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[2]  M. Boussinesq,et al.  Efficacy of repeated doses of ivermectin against Mansonella perstans. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  M. Yazdanbakhsh,et al.  Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood , 2001, The Lancet.

[4]  W. F. Gregory,et al.  Immune evasion genes from filarial nematodes. , 2001, International journal for parasitology.

[5]  D. Molyneux,et al.  Current status and future prospects of the Global Lymphatic Filariasis Programme , 2001, Current opinion in infectious diseases.

[6]  A. Onapa,et al.  Lymphatic filariasis in Uganda: baseline investigations in Lira, Soroti and Katakwi districts. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  P. Das,et al.  Tolerability and efficacy of single‐dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India , 2000, Tropical medicine & international health : TM & IH.

[8]  R. K. Shenoy,et al.  An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis , 2000, Parasitology.

[9]  P. E. Simonsen,et al.  A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  M. Kombila,et al.  Decrease in Mansonella perstans microfilaraemia after albendazole treatment. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[11]  G. Weil,et al.  Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[12]  G. Weil,et al.  The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. , 1997, Parasitology today.

[13]  A. Hightower,et al.  Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children , 1997, The Lancet.

[14]  F. Lipani,et al.  Albendazole for the treatment of Mansonella perstans filariasis. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[15]  S. Adjei,et al.  Descriptive epidemiology of lymphatic filariasis in Ghana. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[16]  J. Chippaux,et al.  Prevalence of L. loa and M. perstans filariasis in southern Cameroon. , 1995, Tropical and geographical medicine.

[17]  J. Rizzo,et al.  Ivermectin treatment of bancroftian filariasis in Recife, Brazil. , 1994, The American journal of tropical medicine and hygiene.

[18]  T. Nutman,et al.  Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. , 1994, The Journal of infectious diseases.

[19]  S. Kar,et al.  Side reactions following ivermectin therapy in high density bancroftian microfilaraemics. , 1993, Acta tropica.

[20]  P. Soboslay,et al.  Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[21]  S. Chanteau,et al.  Results of a safety trial on single-dose treatments with 400 mcg/kg of ivermectin in bancroftian filariasis. , 1992, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[22]  F. Noireau,et al.  Population dynamics of Loa loa and Mansonella perstans infections in individuals living in an endemic area of the Congo. , 1992, The American journal of tropical medicine and hygiene.

[23]  A. Hightower,et al.  Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti. , 1991, The American journal of tropical medicine and hygiene.

[24]  K. Shiwaku,et al.  The occurrence of loiasis, mansonellosis and wuchereriasis in the Jarawa River Valley, central Nigeria. , 1990, Acta tropica.

[25]  J. Roux,et al.  A single diethylcarbamazine dose for treatment of Wuchereria bancrofti carriers in French Polynesia: efficacy and side effects. , 1990, The Southeast Asian journal of tropical medicine and public health.

[26]  A. Sadanandam,et al.  A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. , 1990, The New England journal of medicine.

[27]  G. Prasad,et al.  Efficacy of two different DEC regimens in the treatment of human filarial infection. , 1990, The Indian journal of medical research.

[28]  H. Francis,et al.  The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity. , 1985, The American journal of tropical medicine and hygiene.